DONG Ming-xin,ZHAO Tong,HUANG Jing-zi.Selection of optimal treatment scheme for brain metastases of non-small cell lung cancer[J].Chinese Journal of Radiological Medicine and Protection,2006,26(4):371-373
Selection of optimal treatment scheme for brain metastases of non-small cell lung cancer
Received:January 08, 2006  
DOI:
KeyWords:Brain metastases  Chemotherapy of Vm-26  Gamma knife
FundProject:
Author NameAffiliation
DONG Ming-xin Second Hospital of Northern China College, Jinlin 132022, China 
ZHAO Tong Second Hospital of Northern China College, Jinlin 132022, China 
HUANG Jing-zi Second Hospital of Northern China College, Jinlin 132022, China 
余淑坤 Second Hospital of Northern China College, Jinlin 132022, China 
冯燕 Second Hospital of Northern China College, Jinlin 132022, China 
田中成 Second Hospital of Northern China College, Jinlin 132022, China 
金香顺 Second Hospital of Northern China College, Jinlin 132022, China 
全吉钟 Second Hospital of Northern China College, Jinlin 132022, China 
刘金 Second Hospital of Northern China College, Jinlin 132022, China 
王冬旭 Second Hospital of Northern China College, Jinlin 132022, China 
Hits: 2477
Download times: 1995
Abstract::
      Objective To select the optimal treatment scheme for brain metastases of non-small cell lung cancers (NSCLCs). Methods Seventy-two NSCLC cases diagnosesd by pathology with brain metastases were randomly classified into three groups, Group Ⅰ, 24 cases with whole brain conventional external fractioned irradiation of DT 36-41 Gy/4-5 w, Group Ⅱ, 22 cases with γ-knife treatment plus whole brain conventional external fractioned irradiation, and Group Ⅲ, 26 cases with γ-knife plus whole brain conventional external fractioned irradiation in combination with chemotherapy of Vm-26. The surrounding area of tumor was strictly covered with 50% para-central-dosal curve in γ-knife treatment (DT 16-25 Gy with a mean of 16 Gy). The mult-leaf collimator was selected according to the volume of tumors. Chemotherapy of Vm-26 (60 mg/m2 d1-3) was applied during the treatment with whole brain conventional external fractioned irradiation (DT 19-29 Gy/2-3 w), 21 days in a period, 2 periods in total. Results The median survival time was estimated to be 6.0 months (ranged from 1.2 to 19.0 months) in the Group Ⅰ, 9.2 months (4.4-30 months) in the Group Ⅱ, and 10.8 months (5.2-42.2 months) in the Group Ⅲ. The 1-year and 2-year survival rates were 34.6% and 12.6%, 62.2% and 30.2%, and 70.8% and 35.6% respectively in Group Ⅰ, Group Ⅱ, and Group Ⅲ, respectively. Conclusion For brain metastases of NSCLC, γ-knife plus whole brain conventional external fractioned irradiation combined with treatment of Vm-26 had a significantly beneficial influence on improvement of the local control and 1-year and 2-year survival. There was no complaint about the side-effects of the treatment.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9067450  On-line:0

v
Scan QR Code
&et=B4D843D3B1ADDD8B98822519A3CB2D34E2BD61B39D505721061C33BD7E07C100C2881BB1CE9FEA3ECAFCCD684792F0E29829656FD15AF7BB858D5EAB96B57CB5E1A4470026ED5C212A02412A24B6A5B0B26089BFFEA7025256C9318EFB3220F7&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=37904DC365DD7266&aid=4CA327AFBB0E0C0A&vid=&iid=E158A972A605785F&sid=23410D0BDB501DF5&eid=F4BDB5452F9F5642&fileno=20060419&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="37904DC365DD7266"; var my_aid="4CA327AFBB0E0C0A";